Integrative research: Current trends and considerations for biomarker discovery and precision medicine
Bibliographic record
Abstract
The development of molecular biology, from the discovery of DNA's double-helix to current genomic tools, has revolutionized biomedical science. Integrative research, with the inclusion of genomic, proteomic, and clinical data, plays a critical role in biomarker identification and precision medicine. This review describes how integrative approaches enable better disease classification, such as breast cancer, for targeted therapy and improved patient care. Some of the most important technology advancements—next-generation sequencing, multi-omics integration, artificial intelligence, and single-cell omics—have sped up this field. With the use of directed and undirected biomarker discovery platforms, researchers can identify specific molecular markers or explore novel candidates in different biological layers. These methods have enabled the exploration of complex diseases, from COVID-19 to chronic conditions. Nevertheless, data complexity, computational limitations, and ethical concerns in personalized diagnosis persist. To overcome them, is the key to crossing the gap from computational knowledge into medical application. Enhancing the diagnostics of diseases, improving therapeutics' precision, and facilitating patient therapy are the general objectives of integrated investigations. By advancing the most technology available in computing and molecules, researchers are going towards more precision-guided and effective medicine. • Molecular biology and multi-omics enable targeted therapies and precise disease classification. • Key tools: next-generation sequencing, single-cell omics, AI-driven analytics. • Challenges: data integration, computational demands, clinical translation.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.059 | 0.036 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.003 | 0.002 |
| Bibliometrics | 0.005 | 0.006 |
| Science and technology studies | 0.003 | 0.025 |
| Scholarly communication | 0.015 | 0.029 |
| Open science | 0.005 | 0.008 |
| Research integrity | 0.012 | 0.018 |
| Insufficient payload (model declined to judge) | 0.012 | 0.005 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".